Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene silencing
Biotech
Arrowhead takes aim at obesity with early gene silencing data
Arrowhead has posted preliminary evidence that its molecules help people shed fat, sending its stock up.
Nick Paul Taylor
Jan 6, 2026 10:19am
Alnylam, Biogen build noise in Alzheimer's with gene silencing
Oct 26, 2023 8:51am
Lilly doubles down on ProQR's RNA tech in $75M deal expansion
Dec 22, 2022 10:38am
Alnylam, Regeneron hit go on genetic NASH therapy phase 2
Sep 15, 2022 8:09am
Chinese powerhouse continues charge into siRNA with Silence pact
Oct 15, 2021 7:15am
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab
Sep 8, 2021 4:01pm
